| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/2003 | US20030023067 Follistatin-related protein zfsta2 |
| 01/30/2003 | US20030023066 For therapy and prophylaxis of Helicobacter infection |
| 01/30/2003 | US20030023064 Novel human phosphatases and polynucleotides encoding the same |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023057 Used in assaying for cancer, such as melanoma |
| 01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
| 01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030023049 Site specific protein modification |
| 01/30/2003 | US20030023048 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 01/30/2003 | US20030023046 Vascular endothelial cell growth factor antagonists |
| 01/30/2003 | US20030023044 Human G-Protein chemokine receptor (CCR5) HDGNR10 |
| 01/30/2003 | US20030023041 Method for designing specific ion channel blockers |
| 01/30/2003 | US20030023038 For therapy of undesired cell proliferation; for stimulation and inhibition of lymphocytes |
| 01/30/2003 | US20030023036 Drugs, vaccines |
| 01/30/2003 | US20030023035 Useful as therapeutic agents and in diagnostics |
| 01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
| 01/30/2003 | US20030023033 Novel class II cytokine receptors and uses thereof |
| 01/30/2003 | US20030023032 LuxO-sigma54 interactions and methods of use |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022858 Genes involved in the DNA regulation cascade (cell cycle disorders, DNA repair, tumorigenesis/tumor progression) which are associated with pathophysiology phenotype of Fanconi anaemia |
| 01/30/2003 | US20030022857 Mitogen-activated protein (MAP) kinase phosphatase (MKP) for use in metabolic disorders; gene expression; genetic engineering; diagnosis |
| 01/30/2003 | US20030022855 Melanoma differentiation associated gene-5 (mda-5) nucleic acids, proteins, and gene promoters for induction of apoptotic cell death |
| 01/30/2003 | US20030022851 Long term memory, synaptic plasticity and the ADF1 transcription factor |
| 01/30/2003 | US20030022850 Isolated nucleic acid molecule that hybridizes under stringent conditions or shares 80% sequence identity with a defined genomic region upstream of coding region of G-CSF gene, and DNA construct containing that DNA molecule as target |
| 01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/30/2003 | US20030022841 Growth differentiation factor, Lefty-1 |
| 01/30/2003 | US20030022839 Administering to the subject an amount of a g-protein coupled receptor agonist effective to treat pain, particularly chronic arthritis and inflammatory pain |
| 01/30/2003 | US20030022837 Providing a cell undergoing mitosis with an Emi1 polypeptide, wherein anaphase promoting complex activity in proliferating cell is inhibited |
| 01/30/2003 | US20030022836 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 01/30/2003 | US20030022835 Compositions isolated from skin cells and methods for their use |
| 01/30/2003 | US20030022834 Methods and devices for promoting endothelial morphogenesis |
| 01/30/2003 | US20030022833 Inhibiting proliferation of a breast cancer cell which expresses a prolactin receptor, by exposing cell to a variant of human prolactin having a substitution of the glycine at position 129 |
| 01/30/2003 | US20030022830 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 01/30/2003 | US20030022827 Three new members of the cytokine receptor family class 2 |
| 01/30/2003 | US20030022826 Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents |
| 01/30/2003 | US20030022825 An isolated polynucleotide encoding a polypeptide having stem cell growth factor activity, said polynucleotide hybridizes to the complement of above polynucleotide under stringent hybridization conditions |
| 01/30/2003 | US20030022824 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022821 A modified lactoferrin peptide which is cytotoxic, 7 to 25 amino acids in length, with three or more cationic residues and has one or more extra bulky and lipophilic amino acids as compared to the native lactoferrin seuquence |
| 01/30/2003 | US20030022820 Peptides useful in activating tumor-specific cytotoxic T cells in vivo with specificity for particular antigenic peptides |
| 01/30/2003 | US20030022819 Administering to an animal an angiogenic amount of a hedgehog polypeptide or agonist to promote angiogenesis |
| 01/30/2003 | US20030022374 Modulating photoreactivity in a cell |
| 01/30/2003 | US20030022371 Antifreeze polypeptides for use in prefeation of frozen foods |
| 01/30/2003 | US20030022368 Suppression of differentiation in pluripotent stem cells; obtain stem cells, incubate with suppressor polypetide, monitor cell differentiation |
| 01/30/2003 | US20030022359 Transgenic algae for delivering antigens to an animal |
| 01/30/2003 | US20030022355 Vectors and methods for gene transfer |
| 01/30/2003 | US20030022352 Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein |
| 01/30/2003 | US20030022349 Virulence-associated nucleic acid sequences and uses thereof |
| 01/30/2003 | US20030022345 Human Prt1-like subunit protein (hPrt1) and human eIF4G-like protein (p97) genes |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022332 Polypeptide or use in the treatment prevention and diagnosis of cancer, viral, inflammatory and autoimmune diseqases |
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022330 APOA2-interacting proteins and use thereof |
| 01/30/2003 | US20030022329 Nucleotide sequences coding polypeptide for use in the treatment of nervous system and cell proliferation disorders |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022327 Dendritic enriched secreted lymphocyte activation molecule |
| 01/30/2003 | US20030022326 Nucleotide sequences coding polypeptide for use in tumor therapy |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022322 SAM operon |
| 01/30/2003 | US20030022321 Novel compounds |
| 01/30/2003 | US20030022316 Polypeptide for use in the diagnostic, therapeutic treatment of cell proliferation defects |
| 01/30/2003 | US20030022314 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent |
| 01/30/2003 | US20030022313 Novel neuronal cell growth factor |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022311 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 01/30/2003 | US20030022310 Human G-protein coupled receptor |
| 01/30/2003 | US20030022309 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022305 Nucleotide sequences coding polypeptide for use in the detection of modulators and herbicides |
| 01/30/2003 | US20030022303 Expression vector for use in the treatment of blood disorders |
| 01/30/2003 | US20030022302 Toll-like receptor |
| 01/30/2003 | US20030022301 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022300 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022299 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022297 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 01/30/2003 | US20030022295 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 01/30/2003 | US20030022294 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022293 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022292 Ligation of CEACAM1 |
| 01/30/2003 | US20030022291 Production of a multimeric protein by cell fusion method |
| 01/30/2003 | US20030022290 Method for modulating processes mediated by farnesoid activated receptors |
| 01/30/2003 | US20030022289 Nucleotide sequences coding polypeptide for use in the treatment of pain syndromes and insensitivity, inflammation, ischemia, and immunological defects |
| 01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 01/30/2003 | US20030022287 Non aggregating fluorescent proteins and methods for using the same |
| 01/30/2003 | US20030022286 Novel transporter-like genes and uses therefor |
| 01/30/2003 | US20030022285 Generation of preferential polypeptide with amplified immunogenicity; obtain preferential amino acid and nucleotide sequences, insert data into computer, screen for variant protein with amplified immunogenicity |
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022283 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 01/30/2003 | US20030022282 Nucleotide sequences coding polypeptide for use in the treatment of nervous system, urogenital, psychotherapeutics, gastrointestinal, reproduction and sleep disorders |
| 01/30/2003 | US20030022279 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of kidney and cell proliferation disorders |
| 01/30/2003 | US20030022278 T2R, a novel family of taste receptors |
| 01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
| 01/30/2003 | US20030022276 Dendritic enriched secreted lymphocyte activation molecule |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022261 Co-factors for trophic factors, and methods of use, thereof |
| 01/30/2003 | US20030022258 Regulatory protein for use as wound healing and antiproliferative agent |
| 01/30/2003 | US20030022257 Nucleotide sequences coding polypeptid for use in the diagnosis and prevention of lung cancer |
| 01/30/2003 | US20030022254 Protein for use in the classification, diagnosis, evaluation and treatment of cell proliferative, skin, urogenital, brain and gastrointestinal disorders |
| 01/30/2003 | US20030022237 Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lung |
| 01/30/2003 | US20030022236 Generation of preferental protein libraries; obtain nucleotide sequences, translate in vitro, recover protein product |